Advertisement
Screener

Standard BioTools Inc. (LAB) Material Contracts

Standard BioTools Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-06-18: Form 8-K; Exhibit 10.2; Description Standard BioTools Inc. Amended and Restated 2017 Employee Stock Purchase Plan, as Amended..
  • 2026-06-18: Form 8-K; Exhibit 10.1; Description Standard BioTools Inc. 2026 Equity Incentive Plan..
  • 2026-06-08: Form 8-K; Exhibit 10.3; Description Form of CVR Agreement..
  • 2026-06-08: Form 8-K; Exhibit 10.2; Description Form of Lock-Up Agreement..
FiledFormExhibitDescription
2026-06-188-K10.2Standard BioTools Inc. Amended and Restated 2017 Employee Stock Purchase Plan, as Amended.
2026-06-188-K10.1Standard BioTools Inc. 2026 Equity Incentive Plan.
2026-06-088-K10.3Form of CVR Agreement.
2026-06-088-K10.2Form of Lock-Up Agreement.
2026-06-088-K10.1Form of Voting Agreement.
2026-05-288-K10.52023 Change of Control and Severance Plan and Participation Agreement, dated as of May 22, 2026, by and between Standard BioTools Inc. and Michael Egholm, Ph.D.
2026-05-288-K10.42023 Change of Control and Severance Plan Participation Agreement, as amended and restated.
2026-05-288-K10.32026 Change of Control and Severance Plan Participation Agreement, dated as of May 27, 2026, by and between Standard BioTools Inc. and Sean MacKay.
2026-05-288-K10.22026 Change of Control and Severance Plan Participation Agreement, dated as of May 27, 2026, by and between Standard BioTools Inc. and Alex Kim.
2026-05-288-K10.12026 Change of Control and Severance Plan and Participation Agreement

Similar stocks

Stock NameCountryMarket CapPE Ratio
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01